Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2
R L Medcalf, E Van den Berg, W D Schleuning, R L Medcalf, E Van den Berg, W D Schleuning
Abstract
Constitutive gene expression of four components of plasminogen activating enzyme system, urinary and tissue-type plasminogen activator (u-PA and t-PA), plasminogen activator inhibitor 1 (PAI-1) and PAI-2 in HT-1080 human fibrosarcoma cells, was modulated by the synthetic glucocorticoid dexamethasone (Dex, 10(-7) M). More than 90% of u-PA, t-PA and PAI-1 antigen was found in conditioned medium, whereas PAI-2 was mainly cell associated. In 48-h culture supernatants (expressed per 10(6) cells) PAI-1 antigen increased from 350 to 3,300 ng and t-PA from 19 to 38 ng. u-PA and PAI-2 in the same samples decreased from 380 to 46 ng and from 3.5 to 1.8 ng, respectively. Northern blot hybridization and nuclear "Run-on" transcription assays demonstrated that the increase of t-PA and PAI-1 and the decrease of u-PA were associated with equivalent changes of gene template activity. Modulation of u-PA, t-PA and PAI-1 gene expression by Dex was completely blocked by the glucocorticoid antagonist RU 38486, suggesting that all effects were mediated through the glucocorticoid receptor. Cycloheximide, an inhibitor of protein biosynthesis induced a rapid transient increase of t-PA, u-PA and PAI-1 mRNA and a sustained increase of PAI-2 mRNA, but blocked the more long term effects of Dex, suggesting that both constitutive and hormonally regulated maintenance of mRNA steady state levels required protein biosynthesis.
References
- Nature. 1970 Aug 15;227(5259):680-5
- Mol Cell Biol. 1987 Aug;7(8):3021-5
- J Exp Med. 1978 Jul 1;148(1):223-34
- J Exp Med. 1978 Jun 1;147(6):1695-1712
- Proc Natl Acad Sci U S A. 1978 Dec;75(12):6130-3
- Nature. 1980 Jul 17;286(5770):295-7
- Proc Natl Acad Sci U S A. 1980 Sep;77(9):5201-5
- Thromb Haemost. 1980 Jun 18;43(2):77-89
- Ann N Y Acad Sci. 1981;370:609-16
- Cell. 1981 Aug;25(2):471-6
- Arthritis Rheum. 1981 Oct;24(10):1296-303
- J Biol Chem. 1982 Apr 25;257(8):4260-4
- Nature. 1982 Oct 28;299(5886):797-802
- Hoppe Seylers Z Physiol Chem. 1982 Oct;363(10):1155-65
- Nucleic Acids Res. 1982 Nov 11;10(21):6715-32
- Proc Natl Acad Sci U S A. 1983 May;80(10):2956-60
- Exp Cell Res. 1983 Aug;147(1):177-82
- Mol Cell Biochem. 1983;53-54(1-2):11-21
- Semin Thromb Hemost. 1984 Jan;10(1):61-70
- Mol Cell Biol. 1987 Dec;7(12):4564-7
- Arch Biochem Biophys. 1952 Oct;40(2):346-51
- Nature. 1984 Apr 5-11;308(5959):513-9
- J Biol Chem. 1984 Jun 10;259(11):6847-51
- Nature. 1984 Oct 4-10;311(5985):433-8
- J Biol Chem. 1984 Dec 10;259(23):14914-21
- Cancer Res. 1985 May;45(5):2270-6
- Thromb Haemost. 1985 Feb 18;53(1):122-5
- Endocrinology. 1985 Sep;117(3):1100-9
- J Biol Chem. 1985 Sep 15;260(20):11223-30
- Adv Cancer Res. 1985;44:139-266
- Biochem J. 1985 Aug 15;230(1):109-16
- Biochim Biophys Acta. 1985 Nov 12;823(1):35-65
- Annu Rev Genet. 1985;19:209-52
- Thromb Haemost. 1985 Dec 17;54(4):750-5
- Mol Cell Endocrinol. 1986 May;45(2-3):137-47
- J Biol Chem. 1986 Jul 15;261(20):9309-15
- J Biol Chem. 1986 Aug 25;261(24):11207-13
- Cell. 1986 Aug 29;46(5):659-67
- Proc Natl Acad Sci U S A. 1986 Sep;83(18):6776-80
- EMBO J. 1986 Oct;5(10):2539-44
- EMBO J. 1986 Sep;5(9):2217-22
- J Cell Biol. 1986 Dec;103(6 Pt 1):2403-10
- Proc Natl Acad Sci U S A. 1986 Dec;83(23):8903-7
- Cancer Res. 1987 Jan 15;47(2):364-70
- J Mol Cell Cardiol. 1986 Nov;18(11):1117-24
- J Biol Chem. 1987 Jan 15;262(2):520-3
- J Cell Biol. 1987 Mar;104(3):705-12
- J Exp Med. 1987 Feb 1;165(2):320-39
- Biochem Biophys Res Commun. 1987 Feb 27;143(1):329-36
- J Cell Biol. 1987 Apr;104(4):801-4
- Biochem J. 1987 Mar 1;242(2):387-92
- J Immunol. 1987 Aug 1;139(3):949-55
- Mol Cell Biol. 1987 Apr;7(4):1496-507
- EMBO J. 1987 May;6(5):1281-6
- Blood. 1987 Nov;70(5):1645-53
- Cell. 1976 Jun;8(2):271-81
Source: PubMed